A prescriber's authorisation under section 30 to prescribe a medicine is subject to the following conditions:
(a) the medicine is prescribed in accordance with the Act, section 7 (Appropriate prescription and supply of medicines);
(b) if the prescription is a written prescription—
(i) the prescription complies with section 40 (General requirements for written prescriptions); and
(ii) the prescription includes the particulars mentioned in section 41 on the front of the prescription; and
(iii) if the prescription is faxed by a prescriber to a pharmacist—the prescriber sends the original prescription to the pharmacist not later than 24 hours after the prescriber faxes the prescription to the pharmacist;
Note 1 For the endorsement of faxed prescriptions, see s 41 (1) (l).
Note 2 Pharmacist does not include an intern pharmacist (see dict).
(c) if the prescription is an oral prescription—
(i) the prescriber believes on reasonable grounds that giving an oral prescription for the medicine is reasonably necessary for the patient's treatment; and
(ii) if the prescription is for an unusual or dangerous dose of a medicine—the prescription includes a statement telling the person who is to dispense or administer the medicine that the prescription is for an unusual or dangerous dose; and
(iii) the prescription includes the particulars mentioned in section 41; and
(iv) the prescriber sends a written prescription for the medicine to the pharmacist not later than 24 hours after the prescriber gives the oral prescription to the pharmacist;
Note For the endorsement of written prescriptions confirming oral prescriptions, see s 41 (1) (m).
(d) if the medicine is a controlled medicine for human use—
(i) the prescriber complies with the additional requirements under section 32 for prescribing a controlled medicine; and
(ii) if the controlled medicines approval is an oral approval—the prescriber sends the chief health officer a written application for the approval in accordance with section 561 (Requirements for CHO controlled medicines approval applications) not later than 7 days after the day the oral approval is given;
(e) if the medicine is a designated appendix D medicine prescribed for a purpose mentioned in schedule 3 (Designated appendix D medicines—standing approvals), part 3.2, column 3 in relation to the medicine—the prescriber complies with the additional requirements under section 33 in relation to the prescription.